|
Vero cells
|
35.7 µg/mL
|
Inhibition of DENV-2 replication, DENV-2 RNA reduction
|
Download PDF
|
|
GES-1, AGS, HGC27, NCI-N87
|
GES-1: 327.31 µmol/L, AGS: 41.61 µmol/L, HGC27: 26.76 µmol/L
|
CellTiter 96® AQueous One Solution Cell Proliferation Assay (MTS) Kit
|
PMC11479523
|
|
AGS (control), HGC27 (control), NCI-N87 (control), AGS (NUF2 depleted), HGC27 (NUF2 depleted), NCI-N87 (NUF2 depleted)
|
Control AGS: 42.82 µmol/L, Control HGC27: 29.51 µmol/L, Cont
|
CellTiter 96® AQueous One Solution Cell Proliferation Assay (MTS) Kit
|
PMC11479523
|
|
MKN-45 cells
|
19.27 μmol/L
|
CCK-8 assay, absorbance measured at 450 nm, cell viability expressed as percentage of control values.
|
PMC8088928
|
|
MCF-10AT
|
52.39 µM
|
MTT method, absorbance at 490 nm ([Vendor])
|
Download PDF
|
|
MCF-7
|
53.76 µM
|
MTT method, absorbance at 490 nm ([Vendor])
|
Download PDF
|
|
MDA-MB-231
|
64.23 μM
|
MTT method, absorbance at 490 nm ([Vendor])
|
Download PDF
|
|
Vero cells (SARS-CoV-2 replication)
|
192 µM
|
RT-qPCR analysis of SARS-CoV-2 RNA copies
|
Download PDF
|
|
MDCK cells
|
16.96 μM
|
CCK-8 assay
|
Download PDF
|
|
HepG2, MCF-7
|
37 mM
|
Cell viability assay
|
Download PDF
|
|
Micrococcus flavus
|
0.125 µg/mL
|
Microdilution assay
|
Download PDF
|
|
TRPC5-expressing (Tet+) HEK 293 cells
|
6.5 μM
|
Intracellular Ca2+ measurement using XRhod-1, concentration-response data fitted with Hill equation
|
Download PDF
|
|
A431 human skin cancer cell lines
|
579.05 µM
|
MTT assay
|
Download PDF
|
|
J82
|
29.69 μM
|
CCK8 (Cell Counting Kit-8) assay
|
Download PDF
|
|
EBY.S7 cells expressing GLUT2 ΔloopS_Q455R
|
3.22 ± 0.45 µM
|
Transport activity assay using C14-glucose, followed by filtration, scintillation counting, and nonlinear fit analysis with GraphPad Prism.
|
Download PDF
|
|
EBY.S7 cells expressing GLUT3 S66Y
|
11.6 ± 0.6 µM
|
Transport activity assay using C14-glucose, followed by filtration, scintillation counting, and nonlinear fit analysis with GraphPad Prism.
|
Download PDF
|
|
SCC47
|
27.29 µM (24h), 37.43 µM (48h)
|
Crystal violet assay
|
Download PDF
|
|
FaDu
|
33.15 µM (24h), 34.26 µM (48h)
|
Crystal violet assay
|
Download PDF
|
|
human platelet-rich plasma
|
520.88 µM
|
Light Transmittance Aggregometry
|
Download PDF
|
|
A2058
|
>100 µM
|
resazurin (Alamar Blue) assay; fitting a sigmoid curve on the data points using Microcal ™Origin2021 software
|
Download PDF
|
|
HT-29
|
>100 µM
|
resazurin (Alamar Blue) assay; fitting a sigmoid curve on the data points using Microcal ™Origin2021 software
|
Download PDF
|
|
Vero E6
|
15.9 ± 0.7 µM
|
resazurin (Alamar Blue) assay; fitting a sigmoid curve on the data points using Microcal ™Origin2021 software
|
Download PDF
|
|
Neutrophils
|
0.39 ± 0.03 μM
|
Luminol-dependent chemiluminescence (LCL) assay.
|
Download PDF
|
|
Fibroblasts
|
20 μM
|
Cell Counting Kit-8 (CCK-8)
|
Download PDF
|
|
B16-F10
|
13.7 µM
|
Scratch assay
|
Download PDF
|
|
HK-2 cells
|
50.75 μM
|
CCK-8 assay, CompuSyn software
|
Download PDF
|
|
PMN human leukocytes
|
0.18 ± 0.01 µM (against CIP-induced ROS); 0.13 ± 0.01 µM (ag
|
H2-DCFDA assay
|
Download PDF
|
|
MOLM14 cells
|
24.49 μM
|
Four-parameter logistic curve fitting based on eFluor™506 Viability Dye staining and flow cytometry
|
Download PDF
|
|
HEK293
|
175.96 ± 1.55 µM
|
MTT assay
|
Download PDF
|
|
HCT 116
|
3.7 µM (48 h), 2.1 µM (72 h)
|
MTT assay
|
Download PDF
|
|
hepatic stellate cells (HSCs)
|
27.2 μM
|
proliferation inhibition
|
Download PDF
|
|
OA chondrocytes
|
11.58 μM
|
CCK-8 assay
|
PMC8291879
|
|
A549 cells
|
22 μM
|
Cell viability determined using IN Cell Analyzer 2200 (Hoechst for total nuclei count and ethidium homodimer I for dead cells). IC50 values interpolated from fitted curves using Prism 6.0.
|
Download PDF
|
|
BxPC3 cells
|
37 μM
|
Cell viability determined using IN Cell Analyzer 2200 (Hoechst for total nuclei count and ethidium homodimer I for dead cells). IC50 values interpolated from fitted curves using Prism 6.0.
|
Download PDF
|
|
S. mutans
|
2 mg/mL
|
MIC and MBC assay
|
PMC9618393
|
|
S. sobrinus
|
1 mg/mL
|
MIC and MBC assay
|
PMC9618393
|
|
L. acidophilus
|
2 mg/mL
|
MIC and MBC assay
|
PMC9618393
|
|
S. sanguinis
|
2 mg/mL
|
MIC and MBC assay
|
PMC9618393
|
|
A. actinomycetemocomitans
|
1 mg/mL
|
MIC and MBC assay
|
PMC9618393
|
|
P. intermedia
|
4 mg/mL
|
MIC and MBC assay
|
PMC9618393
|
|
SKOV-3
|
23.4 µM
|
MTT assay
|
PMC5961470
|
|
NCI/ADR
|
320 µM
|
MTT assay
|
PMC5961470
|
|
RAW 264.7 cells
|
12.85 µg/mL (42.52 µM)
|
Nitric oxide production inhibitory assay (Griess reagent)
|
Download PDF
|
|
AGS
|
12.16 µM
|
CCK-8 assay
|
Download PDF
|
|
MGC803
|
8.548 µM
|
CCK-8 assay
|
Download PDF
|
|
RD cells
|
291.2 μM
|
CCK-8 assay
|
Download PDF
|
|
Primary human hepatocytes
|
74.18 mg/mL
|
3D collagen culture, 48 h exposure + 7 d recovery, trypan blue exclusion using a hemocytometer.
|
Download PDF
|
|
M. smegmatis mc2155 cells
|
312.5 μM (48 hours); 225 μM (72 hours)
|
MTT assay
|
Download PDF
|
|
CT26 cells
|
15.67 μg/mL (Qu-M); 24.87 μg/mL (free-Qu)
|
MTT assay
|
PMC4368034
|
|
CEM cells
|
117.4 μM (24h), 25 μM (48h), 15 μM (72h)
|
CCK-8 assay
|
PMC12903035
|
|
NALM-6 cells
|
20 μM
|
CCK-8 assay
|
PMC12903035
|
|
Vero E6 cells
|
83.4 mM
|
Luciferase assay
|
PMC7833040
|
|
hESCs
|
45.35 μM
|
CCK-8 assay
|
Download PDF
|
|
HEC-1-A cells
|
104.2 μM (24h), 59.69 μM (48h)
|
CCK-8 detection of cell activity
|
Download PDF
|
|
A2780
|
192.1 µM
|
CCK-8 analysis, nonlinear regression fitting
|
PMC12924438
|
|
SKOV3
|
83.55 µM
|
CCK-8 analysis, nonlinear regression fitting
|
PMC12924438
|
|
PC-3 cells
|
50.9 µM
|
MTT assay
|
PMC6970612
|
|
HeLa cells
|
4.0 µM
|
MTT assay
|
Download PDF
|
|
HEK cells
|
0.12 mM
|
MTT assay
|
Download PDF
|